Annotated Medicine and Device Lists


Procarbazine

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations
Mexico. Cuadro Basico de Medicamentos - 2017 17. ONCOLOGIA No observations
Chile. Formulario Nacional de Medicamentos. 2005 07.01. CITOTOXICOS O ANTINEOPLASICOS No observations
Guyana. Essential Medicines List. 2020-2021 9.02. 11. Other Anti-neoplastic agents No observations
Haiti. National List of Essential Medicines 08.02 Cytotoxic and adjuvant drugs No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 8.2.1 Cytotoxic medicines No observations
PAHO Strategic Fund Medicine List 3.2. Cytotoxic medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 8.2 Cytotoxics No observations
Ecuador Essential Medicines List - Ecuador No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 08.05 OTHER ANTINEOPLASTIC DRUGS No observations
Suriname. NGK-C-011 8.2 Cytotoxic Agents No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
chlorhydrato INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 18.01. FÁRMACOS CITOTÓXICOS No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Miscellaneous Agents No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 10:00 Anti-neoplastic agents No observations

Information Resources: Procarbazine

Loading ...
Loading ...
Loading ...
No information available